 <h1>Ergotrate Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>ergonovine</i></p><ul class="nav-tabs nav-tabs-collapse nav-tabs-pill">
<li><b class="nav-item here">Side Effects</b></li>
<li>Dosage</li>
<li>Interactions</li>
<li>Pregnancy</li>
<li>Breastfeeding</li>
<li class="nav-more">
More&lt;svg aria-hidden="true" class="ddc-icon ddc-icon-down" focusable="false" height="16" viewbox="0 0 24 24" width="16" xmlns="http://www.w3.org/2000/svg"&gt;&lt;path d="M18.5 7.94L19.56 9 12 16.56 4.44 9 5.5 7.94l6.5 6.5z"&gt;&lt;/path&gt;&lt;/svg&gt;
</li>
</ul><ul>
<li>Managing Side Effects</li>
</ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about ergonovine. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Ergotrate.</p><p><i>Applies to ergonovine: compounding powder, injectable solution, oral tablet</i></p><h3>General</h3><p>Administration of correct dose to carefully selected patients who are closely monitored, yields little risk of serious adverse systemic effects; however, IV administration may produce serious adverse effects if the injections are not diluted and administered slowly.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Frequency not reported</b>: Gangrene, coronary artery vasospasm, peripheral vasospasm, hypotension, hypertension, thrombophlebitis, myocardial infarction (single case report), ventricular arrhythmias, transient chest pain, palpitation, bradycardia, vasoconstriction</p><h3>Gastrointestinal</h3><p><b>Very rare</b> (less than 0.01%): Mesenteric ischemia and large bowel infarction (single case report) </p><p><b>Frequency not reported</b>: Abdominal pain, diarrhea, nausea, esophageal spasm, vomiting, unpleasant taste</p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Allergic phenomena (including shock, hypertension, chest pain, palpitation, dyspnea, and bradycardia), anaphylactic/anaphylactoid reaction</p><h3>Nervous system</h3><p><b>Frequency not reported</b>: Dizziness, headache</p><h3>Metabolic</h3><p><b>Frequency not reported</b>: Clinical exacerbations of porphyria, water intoxication</p><h3>Dermatologic</h3><p><b>Frequency not reported</b>: Sweating, diaphoresis, skin rashes</p><h3>Respiratory</h3><p><b>Frequency not reported</b>: Dyspnea, nasal congestion, pulmonary edema, pleural thickening</p><h3>Musculoskeletal</h3><p><b>Very rare</b> (less than 0.01%): Unmasking of myasthenia gravis (single case report) </p><p><b>Frequency not reported</b>: Leg cramps </p><p><b>Postmarketing reports</b>: Muscle spasm</p><h3>Ocular</h3><p><b>Postmarketing reports</b>: Eye movement disorder</p><h3>Psychiatric</h3><p><b>Frequency not reported</b>: Hallucinations</p><h3>Genitourinary</h3><p><b>Frequency not reported</b>: Hematuria</p><h3>Hepatic</h3><p><b>Frequency not reported</b>: Abnormal liver function test</p><h3>Other</h3><p><b>Frequency not reported</b>: Vertigo, tinnitus</p><h3>Renal</h3><p><b>Postmarketing reports</b>: Increased blood creatine</p><p id="ref_1">1. Cerner Multum,   Inc. "Canadian Product Information." O 0 (2015):</p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><h2>More about Ergotrate (ergonovine)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Drug class: uterotonic agents</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Abnormal Uterine Bleeding</li>
<li>Postpartum Bleeding</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>